Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Quality Index
Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow quality index. Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Quality Index of 0.11x as of December 2023. Operating cash flow of CN¥26.95 Million is below net income of CN¥243.07 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2023)
Cash flow quality index of Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2023. Historical Cash Flow Quality Index for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) net asset quality to measure how much of total assets are equity-financed.
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Quality Index by Year (2019–2023)
Xinxiang Tuoxin Pharmaceutical Co.Ltd. cash flow quality index by year from 2019 to 2023. Year-by-year earnings quality comparison for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For the full cash flow conversion analysis, see 301089 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.11x | CN¥26.95 Million | CN¥243.07 Million | ▼ -88.2% |
| 2022 | 0.94x | CN¥268.85 Million | CN¥286.54 Million | ▲ +5.9% |
| 2021 | 0.89x | CN¥58.19 Million | CN¥65.71 Million | ▼ -16.8% |
| 2020 | 1.06x | CN¥120.00 Million | CN¥112.80 Million | ▼ -24.6% |
| 2019 | 1.41x | CN¥86.38 Million | CN¥61.25 Million | — |